World's Best Scientists 2026 revealed!
Marina Cavazzana-Calvo

Marina Cavazzana-Calvo

D-Index & Metrics

Biology and Biochemistry

D-Index
85
Citations
37979
World Ranking
3076
National Ranking
71

Medicine

D-Index
85
Citations
38013
World Ranking
14397
National Ranking
462

Marina Cavazzana-Calvo publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Marina Cavazzana-Calvo sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 273 publications — 73rd percentile

73% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Marina Cavazzana-Calvo D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Marina Cavazzana-Calvo sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 85 D-Index — 84th percentile

84% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

What is she best known for?

The fields of study she is best known for:

  • Gene
  • Cancer
  • Internal medicine

Marina Cavazzana-Calvo mostly deals with Immunology, Severe combined immunodeficiency, Transplantation, Hematopoietic stem cell transplantation and Genetic enhancement. Her Immunology research is multidisciplinary, relying on both Haematopoiesis and Disease. Marina Cavazzana-Calvo has included themes like Insertional mutagenesis, Cancer research, Internal medicine, Lymphocyte and DNA repair in her Severe combined immunodeficiency study.

She interconnects Survival analysis, Stem cell, Retrospective cohort study and Immunopathology in the investigation of issues within Transplantation. The Hematopoietic stem cell transplantation study combines topics in areas such as Survival rate, Combined immunodeficiencies and Graft-versus-host disease. Her Genetic enhancement research is multidisciplinary, incorporating perspectives in Progenitor cell and Leukemia.

Her most cited work include:

  • LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. (3006 citations)
  • Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease (2298 citations)
  • A Serious Adverse Event after Successful Gene Therapy for X-Linked Severe Combined Immunodeficiency (1589 citations)

What are the main themes of her work throughout her whole career to date?

Her primary areas of study are Immunology, Genetic enhancement, Transplantation, Severe combined immunodeficiency and Stem cell. The study incorporates disciplines such as Progenitor cell, Hematopoietic stem cell transplantation and Haematopoiesis in addition to Immunology. Her work in Genetic enhancement tackles topics such as Combined immunodeficiencies which are related to areas like Transgene.

Her Transplantation study incorporates themes from Immunopathology and Immunodeficiency. Her Severe combined immunodeficiency research incorporates themes from Molecular biology, Cancer research and Virology. Her Stem cell research includes themes of T cell and Cell.

She most often published in these fields:

  • Immunology (69.23%)
  • Genetic enhancement (44.48%)
  • Transplantation (43.14%)

What were the highlights of her more recent work (between 2010-2019)?

  • Immunology (69.23%)
  • Genetic enhancement (44.48%)
  • Severe combined immunodeficiency (39.80%)

In recent papers she was focusing on the following fields of study:

Her scientific interests lie mostly in Immunology, Genetic enhancement, Severe combined immunodeficiency, Transplantation and Stem cell. Her studies in Immunology integrate themes in fields like Hematopoietic stem cell transplantation, Haematopoiesis, Progenitor cell, CD34 and Cell biology. She has researched Genetic enhancement in several fields, including Viral vector and Bioinformatics.

Her Severe combined immunodeficiency study combines topics from a wide range of disciplines, such as Retrovirus, Leukemia, Recombination-activating gene and Virology. Her Transplantation research is included under the broader classification of Internal medicine. Her research integrates issues of Spinal muscular atrophy, Survival of motor neuron, Skeletal muscle, Myocyte and Amniotic stem cells in her study of Stem cell.

Between 2010 and 2019, her most popular works were:

  • Long-term outcome and lineage-specific chimerism in 194 patients with Wiskott-Aldrich syndrome treated by hematopoietic cell transplantation in the period 1980-2009: an international collaborative study (205 citations)
  • X-linked lymphoproliferative disease due to SAP/SH2D1A deficiency: a multicenter study on the manifestations, management, and outcome of the disease (201 citations)
  • Bone marrow failure in Fanconi anemia is triggered by an exacerbated p53/p21 DNA damage response that impairs hematopoietic stem and progenitor cells. (201 citations)

In her most recent research, the most cited papers focused on:

  • Gene
  • Cancer
  • Mutation

Her scientific interests lie mostly in Immunology, Hematopoietic stem cell transplantation, Genetic enhancement, Internal medicine and Severe combined immunodeficiency. Her studies in Immunology integrate themes in fields like Progenitor cell, Haematopoiesis, Stem cell and Amniotic stem cells. Marina Cavazzana-Calvo interconnects X-linked lymphoproliferative disease and Immune dysregulation in the investigation of issues within Hematopoietic stem cell transplantation.

Her Genetic enhancement research is multidisciplinary, relying on both Gene targeting, Hematopoietic stem cell, Viral vector and Bioinformatics. Her specific area of interest is Internal medicine, where she studies Transplantation. Her Severe combined immunodeficiency research includes themes of Leukemia, Wiskott–Aldrich syndrome and Oncology.

Best Publications

  • LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1.

    S. Hacein-Bey-Abina;C. Von Kalle;C. Von Kalle;M. Schmidt;M. P. McCormack

  • Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease

    Marina Cavazzana-Calvo;Salima Hacein-Bey;Geneviève De Saint Basile;Fabian Gross

  • A Serious Adverse Event after Successful Gene Therapy for X-Linked Severe Combined Immunodeficiency

    Salima Hacein-Bey-Abina;Christof Von Kalle;Manfred Schmidt;Françoise Le Deist

  • Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1

    Salima Hacein-Bey-Abina;Alexandrine Garrigue;Gary P. Wang;Jean Soulier

  • Hematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked Adrenoleukodystrophy

    Nathalie Cartier;Salima Hacein-Bey-Abina;Cynthia C. Bartholomae;Gabor Veres

  • Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia

    Marina Cavazzana-Calvo;Emmanuel Payen;Olivier Negre;Gary Wang

  • Sustained Correction of X-Linked Severe Combined Immunodeficiency by ex Vivo Gene Therapy

    Salima Hacein-Bey-Abina;Françoise Le Deist;Frédérique Carlier;Cécile Bouneaud

  • Artemis, a Novel DNA Double-Strand Break Repair/V(D)J Recombination Protein, Is Mutated in Human Severe Combined Immune Deficiency

    Despina Moshous;Isabelle Callebaut;Régina de Chasseval;Barbara Corneo

  • Efficacy of Gene Therapy for X-Linked Severe Combined Immunodeficiency

    Salima Hacein-Bey-Abina;Julia Hauer;Annick Lim;Capucine Picard

  • Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968–99

    Corinne Antoine;Susanna Müller;Andrew Cant;Marina Cavazzana-Calvo

  • Transplantation of hematopoietic stem cells and long-term survival for primary immunodeficiencies in Europe: Entering a new century, do we do better?

    Andrew R. Gennery;Andrew R. Gennery;Mary A. Slatter;Mary A. Slatter;Laure Grandin;Pierre Taupin

  • Autoimmunity in Wiskott-Aldrich syndrome: risk factors, clinical features, and outcome in a single-center cohort of 55 patients.

    Sophie Dupuis-Girod;Jacques Medioni;Elie Haddad;Pierre Quartier

  • Bone marrow failure in Fanconi anemia is triggered by an exacerbated p53/p21 DNA damage response that impairs hematopoietic stem and progenitor cells.

    Raphael Ceccaldi;Raphael Ceccaldi;Kalindi Parmar;Enguerran Mouly;Marc Delord

  • Long-term outcome and lineage-specific chimerism in 194 patients with Wiskott-Aldrich syndrome treated by hematopoietic cell transplantation in the period 1980-2009: an international collaborative study

    Daniele Moratto;Silvia Giliani;Carmem Bonfim;Evelina Mazzolari

  • Long-Term Immune Reconstitution and Outcome After HLA-Nonidentical T-Cell–Depleted Bone Marrow Transplantation for Severe Combined Immunodeficiency: A European Retrospective Study of 116 Patients

    Elie Haddad;Paul Landais;Wilhelm Friedrich;Bert Gerritsen

  • X-linked lymphoproliferative disease due to SAP/SH2D1A deficiency: a multicenter study on the manifestations, management, and outcome of the disease

    Claire Booth;Kimberly C. Gilmour;Paul Veys;Andrew R. Gennery

  • The future of gene therapy

    Marina Cavazzana-Calvo;Adrian Thrasher;Fulvio Mavilio

  • Hematopoietic stem cell transplantation in hemophagocytic lymphohistiocytosis: a single-center report of 48 patients.

    Marie Ouachée-Chardin;Caroline Elie;Geneviève de Saint Basile;Françoise Le Deist

  • Immune reconstitution without graft-versus-host disease after haemopoietic stem-cell transplantation: a phase 1/2 study

    Isabelle André-Schmutz;Françoise Le Deist;Salima Hacein-Bey-Abina;Ellen Vitetta

  • Efficacy of gene therapy for X-linked severe combined immunodeficiency: update on trial No.1 follow-up and preliminary results of multicentric collaborative trial No. 2 (Paris - Boston - London)

    S Hacein-Bey-Abina;L Caccaveli;F Touzot;L Dal-Cortivo

Frequent Co-Authors

Alain Fischer
Alain Fischer Collège de France
Stéphane Blanche
Stéphane Blanche Université Paris Cité
Françoise Le Deist
Françoise Le Deist University of Montreal
Anne-Marie Fischer
Anne-Marie Fischer Université Paris Cité
Adrian J. Thrasher
Adrian J. Thrasher University College London
Bénédicte Neven
Bénédicte Neven Université Paris Cité
Jean-Pierre de Villartay
Jean-Pierre de Villartay Université Paris Cité
Capucine Picard
Capucine Picard Université Paris Cité
Despina Moshous
Despina Moshous Necker-Enfants Malades Hospital
F. Le Deist
F. Le Deist Necker-Enfants Malades Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Biology and Biochemistry in the USA opens up a range of versatile online degree options and flexible career pathways. Many students opt for healthcare careers, where accelerated programs can make a significant difference. Those holding advanced nursing credentials may be interested in the shortest post master's fnp program to quickly expand their qualifications and take on new clinical roles.

Nutrition and wellness are also popular choices, with various accredited institutions offering a online nutrition degree at a lower cost, making the field accessible for more students. Registered nurses looking to further their education can benefit from the easiest rn to bsn online program, which streamlines licensure upgrades essential for career advancement.

For those aiming for leadership roles in healthcare, pursuing the fastest online master's in healthcare management can provide management skills and industry knowledge in a fraction of the time. With so many online options, students can align their education with their career goals efficiently and cost-effectively.

Best Scientists Citing Marina Cavazzana-Calvo

Trending Scientists

Recently Published Articles